Suppr超能文献

肿瘤相关巨噬细胞浸润在非小细胞肺癌中的预后影响:一项系统评价和荟萃分析。

Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.

作者信息

Mei Jiandong, Xiao Zhilan, Guo Chenglin, Pu Qiang, Ma Lin, Liu Chengwu, Lin Feng, Liao Hu, You Zongbing, Liu Lunxu

机构信息

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu 610041, China.

出版信息

Oncotarget. 2016 Jun 7;7(23):34217-28. doi: 10.18632/oncotarget.9079.

Abstract

Tumor-associated macrophages (TAMs) are important components of cancer microenvironment. In the present study, we searched PubMed, Embase, Cochrane library and Web of Science to perform a meta-analysis of 20 studies including a total of 2,572 non-small cell lung cancer (NSCLC) patients, in order to determine the association between TAMs and NSCLC prognosis. The combined hazard ratio (HR) of 9 studies showed that the density of total CD68+ TAMs in the tumor islet and stroma was not associated with overall survival (OS) of the patients. However, the pooled HR of 4 studies showed that high density of CD68+ TAMs in the tumor islet predicted better OS, while the pooled HR of 6 studies showed that high density of CD68+ TAMs in the tumor stroma was associated with poor OS. A high islet/stroma ratio of CD68+ TAMs was associated with better OS. A high density of M1 TAMs in the tumor islet was associated with better OS, while a high density of M2 TAMs in the tumor stroma predicted poor OS. These findings suggest that, although the density of total CD68+ TAMs is not associated with OS, the localization and M1/M2 polarization of TAMs are potential prognostic predictors of NSCLC.

摘要

肿瘤相关巨噬细胞(TAMs)是癌症微环境的重要组成部分。在本研究中,我们检索了PubMed、Embase、Cochrane图书馆和科学网,对20项研究进行荟萃分析,这些研究共纳入2572例非小细胞肺癌(NSCLC)患者,以确定TAMs与NSCLC预后之间的关联。9项研究的合并风险比(HR)显示,肿瘤胰岛和基质中总CD68+ TAMs的密度与患者的总生存期(OS)无关。然而,4项研究的合并HR显示,肿瘤胰岛中CD68+ TAMs的高密度预示着更好的OS,而6项研究的合并HR显示,肿瘤基质中CD68+ TAMs的高密度与较差的OS相关。CD68+ TAMs的高胰岛/基质比与更好的OS相关。肿瘤胰岛中高密度的M1 TAMs与更好的OS相关,而肿瘤基质中高密度的M2 TAMs预示着较差的OS。这些发现表明,尽管总CD68+ TAMs的密度与OS无关,但TAMs的定位和M1/M2极化是NSCLC潜在的预后预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b86f/5085150/83e150e8306a/oncotarget-07-34217-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验